Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl fumarate for hospitalized adults with COVID-19
IRCT20201024049134N4Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Dimethyl fumarate + national standard treatment with Placebo + national standard treatment (2 arms). Primary endpoints: Need for mechanical ventilation and Death. Started Nov 2021; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201024049134N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201024049134N4.